今日盘中，东阳光长江药业（01558）股价出现大幅上涨，涨幅高达5.06%，引起市场广泛关注。
根据最新数据显示，南向资金对东阳光长江药业的持续看好可能是推动股价上涨的主要原因。3月31日，南向资金增持东阳光长江药业131.62万股，这已经是连续第5个交易日增持该股。截至3月31日收盘，港股通共持有东阳光长江药业16851.92万股，占流通股的25.78%，显示出内地投资者对该股的浓厚兴趣。
值得注意的是，尽管东阳光长江药业在近5个交易日内下跌了5.37%，但港股通在此期间仍累计增持了694.70万股。这种逆势增持的行为或表明机构投资者对公司未来发展前景持乐观态度。今日的大幅上涨可能是市场对近期累积买盘的反应，投资者应密切关注该股后续走势。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.